Eastman(US:EMN) ZACKSยท2025-04-24 23:05Core Insights - Eastman Chemical (EMN) reported revenue of $2.29 billion for Q1 2025, a year-over-year decline of 0.9% and a surprise of -0.81% compared to the Zacks Consensus Estimate of $2.31 billion [1] - The company's EPS for the same period was $1.91, up from $1.61 a year ago, exceeding the consensus estimate of $1.89 by +1.06% [1] Revenue Performance - Net Sales in Chemical Intermediates reached $545 million, exceeding the average estimate of $526.41 million, with a year-over-year increase of +4.2% [4] - Net Sales in Fibers were $288 million, below the average estimate of $323.18 million, reflecting a year-over-year decline of -13% [4] - Net Sales in Advanced Materials totaled $719 million, compared to the average estimate of $764.65 million, marking a year-over-year decrease of -3.9% [4] - Net Sales in Additives & Functional Products were $733 million, surpassing the average estimate of $706.46 million, with a year-over-year increase of +4.1% [4] - Net Sales in Other products amounted to $5 million, slightly above the average estimate of $4.50 million, representing a year-over-year increase of +25% [4] Adjusted EBIT Performance - Adjusted EBIT for Additives & Functional Products was $141 million, exceeding the average estimate of $127.78 million [4] - Adjusted EBIT for Advanced Materials reached $116 million, slightly above the average estimate of $114.17 million [4] - Adjusted EBIT for Chemical Intermediates was $19 million, below the average estimate of $22.78 million [4] - Adjusted EBIT for Other products was -$53 million, in line with the average estimate of -$53.70 million [4] - Adjusted EBIT for Fibers was $88 million, below the average estimate of $98.13 million [4] Stock Performance - Eastman Chemical's shares have returned -12% over the past month, compared to a -5.1% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]